A critical appraisal of treatment decisions in multiple sclerosis—old versus new
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A critical appraisal of treatment decisions in multiple sclerosis—old versus new
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume 7, Issue 5, Pages 255-262
Publisher
Springer Nature
Online
2011-04-06
DOI
10.1038/nrneurol.2011.41
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Natalizumab drug holiday in multiple sclerosis: Poorly Tolerated
- (2010) Joep Killestein et al. ANNALS OF NEUROLOGY
- Considerations on discontinuing natalizumab for the treatment of multiple sclerosis
- (2010) Joseph R. Berger et al. ANNALS OF NEUROLOGY
- Natalizumab dosage suspension: Are we helping or hurting?
- (2010) Timothy W. West et al. ANNALS OF NEUROLOGY
- Anti-JC virus antibodies: Implications for PML Risk Stratification
- (2010) Leonid Gorelik et al. ANNALS OF NEUROLOGY
- Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity
- (2010) Joanne L. Jones et al. BRAIN
- Quality of Life in Multiple Sclerosis: Determinants, Measurement, and Use in Clinical Practice
- (2010) Deborah M. Miller et al. Current Neurology and Neuroscience Reports
- Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
- (2010) David B Clifford et al. LANCET NEUROLOGY
- The changing demographic pattern of multiple sclerosis epidemiology
- (2010) Nils Koch-Henriksen et al. LANCET NEUROLOGY
- Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
- (2010) Christoph Heesen et al. Multiple Sclerosis Journal
- Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS
- (2010) E. Kingwell et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA
- (2009) Bruce A. C. Cree et al. ARCHIVES OF NEUROLOGY
- ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis
- (2009) S. Cotte et al. BRAIN
- Long-term experience with induction treatment regimens in multiple sclerosis
- (2009) Emmanuelle Le Page et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Immunosuppression followed by immunomodulation
- (2009) Mike Boggild JOURNAL OF THE NEUROLOGICAL SCIENCES
- Health and quality of life in patients with relapsing multiple sclerosis: making the intangible tangible
- (2009) Howard Zwibel JOURNAL OF THE NEUROLOGICAL SCIENCES
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
- (2009) Eva Havrdova et al. LANCET NEUROLOGY
- 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
- (2009) Paul O'Connor et al. LANCET NEUROLOGY
- Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?
- (2009) R Ellis et al. Multiple Sclerosis Journal
- The present efficacy of multiple sclerosis therapeutics: Is the new 66% just the old 33%?
- (2009) E. C. Klawiter et al. NEUROLOGY
- SEVERE CARDIAC FAILURE IN A PATIENT WITH MULTIPLE SCLEROSIS FOLLOWING LOW-DOSE MITOXANTRONE TREATMENT
- (2009) J. Dorr et al. NEUROLOGY
- The future of multiple sclerosis therapy☆
- (2009) Bernd C. Kieseier et al. PHARMACOLOGICAL RESEARCH
- Will Rogers phenomenon in multiple sclerosis
- (2008) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- Health-Related Quality of Life in Multiple Sclerosis
- (2008) Richard A Rudick et al. CNS DRUGS
- Safety-Related Regulatory Actions for Biologicals Approved in the United States and the European Union
- (2008) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cognitive impairment in multiple sclerosis
- (2008) Nancy D Chiaravalloti et al. LANCET NEUROLOGY
- Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
- (2008) Daniel D Mikol et al. LANCET NEUROLOGY
- Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis
- (2008) T Vollmer et al. Multiple Sclerosis Journal
- Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy
- (2008) O. Stuve et al. NEUROLOGY
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Identification and development of new therapeutics for multiple sclerosis
- (2008) Ralf A. Linker et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now